WEST CONSHOHOCKEN, Pa. (AP) — WEST CONSHOHOCKEN, Pa. (AP) — Madrigal Pharmaceuticals Inc. (MDGL) on Thursday reported a loss of $107 million in its third quarter.
On a per-share basis, the West Conshohocken, Pennsylvania-based company said it had a loss of $4.92.
The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of $6.94 per share.
The biopharmaceutical company posted revenue of $62.2 million in the period, which also topped Street forecasts. Seven analysts surveyed by Zacks expected $33.4 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MDGL at https://www.zacks.com/ap/MDGL
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
